Intrauterine devices and reproductive health: American women in feast and famine

Contraception

Volumn 69, Issue 6, 2004, Pages 437-446

  Hubacher, David ^a   Cheng, Diana ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b Center for Maternal and Child Health   (United States)

Author keywords

History; Impact; IUD; Prevalence; Reproductive health; United States

Indexed keywords

ADOLESCENT; ADULT; BIRTH CONTROL; FAMILY PLANNING; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HUNGER; INTRAUTERINE CONTRACEPTIVE DEVICE; MASS MEDIUM; REPRODUCTIVE HEALTH; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

HUMANS; INTRAUTERINE DEVICES; UNITED STATES;

EID: 2442418098     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.01.009     Document Type: Review

References (76)

1. Mosher W.D., Westoff C.F. Trends in contraceptive practice United States, 1965-76. Vital Health Stat. 23:1982;1-47
2. Piccinino L.J., Mosher W.D. Trends in contraceptive use in the United States 1982-1995. Fam Plann Perspect. 30:1998;4-10., 46
3. Zipper J.A., Tatum H.J., Pastene L., Medel M., Rivera M. Metallic copper as an intrauterine contraceptive adjunct to the "T" device. Am J Obstet Gynecol. 105:1969;1274-1278
4. Mamana, J. Sworn testimony before the US Senate. Food and Drug Administration Practice and Procedure, 1975: Report of safety and efficacy of the Dalkon Shield and other IUDs. Joint Hearings before the Subcomm. on Health of the Comm. on Labor and Public Welfare and the Subcomm. on Administrative Practice and Procedure of the Comm. on the Judiciary. United States Senate. 94th Cong., 1st Sess. (January 28, 1975)
5. Wallach M., Grimes D.A. Modern oral contraception updates from the contraception report. 2000;Emron, Totowa (NJ)
6. Tietze C. Intra-uterine contraceptives rings: history and statistical appraisal. In: Tietze C, Lewit S, editors. Intra-uterine contraceptive devices. Proceedings of the conference. April 30-May 1, 1962. New York City. Amsterdam: Excerpta Medica International Congress, Series No. 54, 1962
7. Kopp M.E. Birth control in practice. 1972;Arno Press, Inc, New York
8. Halton M., Dickinson R.L., Tietze C. Contraception with an intrauterine silk coil. Hum Fertil. 13:1948;10-13
9. Thomsen R.J. An atlas of intrauterine contraception. 1982;Hemisphere Publishing Corp, Washington (DC)
10. Westoff C.F., Ryder N.B. United States methods of fertility control, 1955, 1960, & 1965. Stud Fam Plann. 17:1967;1-5
11. Davis H.J. Intrauterine devices for contraception. 1971;Williams & Wilkins Co, Baltimore (MD)
12. Oppenheimer W. Prevention of pregnancy by the Graefenberg ring method. Am J Obstet Gynecol. 78:1959;446-454
13. Ishihama A. Clinical studies on intrauterine rings, especially the present state of contraception in Japan and the experiences in the use of intrauterine rings. Yokohama Med J. 10:1959;89-105
14. Tietze C, Lewit S. Intra-uterine contraceptive devices. Proceedings of the Conference. New York City. April 30-May 1, 1962. Amsterdam: Excerpta Medica International Congress Series No. 54, 1962
15. Segal SJ, Southam AL, Shafer KD. Intra-uterine contraception. Proceedings of the Second International Conference. New York City. Amsterdam: Excerpta Medica International Congress Series No. 86, 1965
16. Advisory Committee on Obstetrics and Gynecology. Food and Drug Administration. Report on Intrauterine Contraceptive Devices. 1968;US Department of Health, Education, and Welfare, Washington (DC)
17. Ryder N.B. Time series of pill and IUD use United States, 1961-1970. Stud Fam Plann. 3:1972;233-240
18. Tone A. Devices and desires. A history of contraceptives in America. 2001;Hill and Wang, New York
19. Food and Drug Administration Practice and Procedure, 1975. Report of Safety and Efficacy of the Dalkon Shield and Other IUDs. Joint Hearings before the Subcomm. on Health of the Comm. on Labor and Public Welfare and the Subcomm. on Administrative Practice and Procedure of the Comm. on the Judiciary. United States Senate. 94th Cong., 1st Sess. (January 28, 1975)
20. Schwartz M.E. The Dalkon Shield tale of a tail. Fam Plann Perspect. 6:1974;198-201
21. Perlmutter J.F. Experience with the Dalkon Shield as a contraceptive device. Obstet Gynecol. 43:1974;443-446
22. Kahn H.S., Tyler C.W. An association between the Dalkon Shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device-related disorders. Am J Obstet Gynecol. 125:1976;83-86
23. Cates W., Ory H.W., Rochat R.W., Tyler C.W. The intrauterine device and deaths from spontaneous abortion. N Engl J Med. 295:1976;1155-1159
24. Cates W., Grimes D.A., Ory H.W., Tyler C.W. Publicity and the public health the elimination of IUD-related abortion deaths. Fam Plann Perspect. 9:1977;138-140
25. Tatum H.J., Schmidt F.H., Phillips D., McCarty M., O'Leary W.M. The Dalkon Shield controversy. Structural and bacteriological studies of IUD tails. JAMA. 231:1975;711-717
26. Mishell D.R., Bell J.H., Good R.G., Moyer D.L. The intrauterine device a bacteriologic study of the endometrial cavity. Am J Obstet Gynecol. 96:1966;119-126
27. Jones E.F., Beniger J.R., Westoff C.F. Pill and IUD discontinuation in the United States, 1970-1975 the influence of the media. Fam Plann Perspect. 12:1980;293-300
28. Perry S. Nightmare: women and the Dalkon Shield. 1985;Macmillan Publishing Co, New York
29. Harvard Law School. News and events. Harvard Law School Library receives 1970s-era Dalkon Shield litigation papers. Available at: http://www.law.harvard. edu/news/2000/09/15_librarydalkon.html. Accessed January 27, 2004
30. Harrison P., Rosenfield A. Contraceptive research and development looking to the future. 1996;Institute of Medicine, National Academy Press, Washington (DC)
31. Forrest J.D., Fordyce R.R. U.S. women's contraceptive attitudes and practice how have they changed in the 1980s? Fam Plann Perspect. 20:1988;112-118
32. Forrest J.D. The end of IUD marketing in the United States what does it mean for American women? Fam Plann Perspect. 18:1986;52-57
33. Dryfoos J.G., Jaffe F.S., Weintraub D.R., Cobb J.P., Bernsohn C.J. Eighteen months later family planning services in the United States, 1969. Fam Plann Perspect. 3:1971;29-44
34. Corey M. U.S. organized family planning programs in FY 1974. Fam Plann Perspect. 7:1975;98-103
35. Dryfoos J.G. Family planning clinics - a story of growth and conflict. Fam Plann Perspect. 20:1988;282-287
36. Torres A., Forrest J.D. Family planning clinic services in the United States, 1981. Fam Plann Perspect. 15:1983;272-278
37. The Alan Guttmacher Institute. Current functioning and future priorities in family planning services delivery. 1983;The Alan Guttmacher Institute, New York (NY)
38. Smith J.C., Franchino B., Henneberry J.F. Surveillance of family planning services at Title X clinics and characteristics of women receiving these services, 1991. MMWR CDC Surveill Summ. 44:1995;1-21
39. Finer L.B., Darroch J.E., Frost J.J. U.S. agencies providing publicly funded contraceptive services in 1999. Perspect Sex Reprod Health. 34:2002;15-24
40. Frost J.J. Public or private providers? U.S. women's use of reproductive health services. Fam Plann Perspect. 33:2001;4-12
41. Gostin L.O. Public health law: power, duty, restraint. 2000;University of California Press, Berkeley (CA)
42. Tietze C. Contraception with intrauterine devices. 1959-1966. Am J Obstet Gynecol. 96:1966;1043-1054
43. th ed:1972;Emory University, Altanta (GA)
44. Mishell D.R., Moyer D.L. Association of pelvic inflammatory disease with the intrauterine device. Clin Obstet Gynecol. 12:1969;179-197
45. Jacobson L., Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol. 105:1969;1088-1098
46. Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol. 121:1975;707-713
47. th ed:1976;Irvington Publishers, Inc, New York
48. Hutchings J.E., Benson P.J., Perkin G.W., Soderstrom R.M. The IUD after 20 years a review. Fam Plann Perspect. 17:1985;244-247., 250-5
49. Lee N.C., Rubin G.L., Borucki R. The intrauterine device and pelvic inflammatory disease revisited new results from the Women's Health Study. Obstet Gynecol. 72:1988;1-6
50. Lee N.C., Rubin G.L., Ory H.W., Burkman R.T. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol. 62:1983;1-6
51. Cramer D.W., Schiff I., Schoenbaum S.C., et al. Tubal infertility and the intrauterine device. N Engl J Med. 312:1985;941-947
52. Daling J.R., Weiss N.S., Metch B.J., et al. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med. 312:1985;937-941
53. Daling J.R., Weiss N.S., Voigt L.F., McKnight B., Moore D.E. The intrauterine device and primary tubal infertility. [letter] N Engl J Med. 326:1992;203-204
54. Farley T.M., Rosenberg M.J., Rowe P.J., Chen J.H., Meirik O. Intrauterine devices and pelvic inflammatory disease an international perspective. Lancet. 339:1992;785-788
55. Hubacher D., Lara-Ricalde R., Taylor D.J., Guerra-Infante F., Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 345:2001;561-567
56. US Food and Drug Administration. New labeling to provide information about contraceptives and STDs. FDA Med Bull. 23:1993;4-5
57. th ed:1998;Ardent Media, Inc, New York
58. Hubacher D., Grimes D.A. Noncontraceptive health benefits of intrauterine devices a systematic review. Obstet Gynecol Surv. 57:2002;120-128
59. The Alan Guttmacher Institute. Family planning annual report 2001. Available at: http://www.agi-usa.org/pubs/FPAR2001.pdf. Accessed January 27, 2004
60. Trussell J., Vaughan B., Stanford J. Are all contraceptive failures unintended pregnancies? Evidence from the 1995 National Survey of Family Growth. Fam Plann Perspect. 31:1999;246-247., 260
61. Forrest J.D. Epidemiology of unintended pregnancy and contraceptive use. Am J Obstet Gynecol. 170:1994;1485-1489
62. Henshaw S.K. Unintended pregnancy in the United States. Fam Plann Perspect. 30:1998;24-29., 46
63. Berg C.J., Chang J., Callaghan W.M., Whitehead S.J. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol. 101:2003;289-296
64. Lawson H.W., Frye A., Atrash H.K., Smith J.C., Shulman H.B., Ramick M. Abortion mortality, United States, 1972 through 1987. Am J Obstet Gynecol. 171:1994;1365-1372
65. Berman S.M., MacKay H.T., Grimes D.A., Binkin N.J. Deaths from spontaneous abortion in the United States. JAMA. 253:1985;3119-3123
66. Grimes D.A. The morbidity and mortality of pregnancy still risky business. Am J Obstet Gynecol. 170:1994;1489-1494
67. Hillis S.D., Marchbanks P.A., Tylor L.R., Peterson H.B. Poststerilization regret findings from the United States Collaborative Review of Sterilization. Obstet Gynecol. 93:1999;889-895
68. Ventura S.J., Mosher W.D., Curtin S.C., Abma J.C., Henshaw S. Trends in pregnancy rates for the United States, 1976-97 an update. Natl Vital Stat Rep. 49:2001;1-9
69. Boonstra H., Duran V., Gamble V.N., Blumenthal P., Dominguez L., Pies C. The "boom and bust phenomenon:" the hopes, dreams, and broken promises of the contraceptive revolution. Contraception. 61:2000;9-25
70. Kost K., Forrest J.D., Harlap S. Comparing the health risks and benefits of contraceptive choices. Fam Plann Perspect. 23:1991;54-61
71. Ory H.W. Mortality associated with fertility and fertility control 1983. Fam Plann Perspect. 15:1983;57-63
72. Schwingl P.J., Ory H.W., Visness C.M. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States. Am J Obstet Gynecol. 180:1999;241-249
73. Population Reference Bureau. Family Planning Worldwide 2002 Data Sheet. Available at: www.prb.org/pdf/FamPlanWorldwide_Eng.pdf. Accessed on January 27, 2004
74. Ford K. Contraceptive utilization United States. Vital Health Stat. 23:1979;1-48
75. Mosher W.D. Contraceptive utilization United States, 1976. Vital Health Stat. 23:1981;1-58
76. Ford K. Use of intrauterine contraceptive devices in the United States. Advance Data From Vital and Health Statistics 43;1978. Hyattsville (MD): National Center for Health Statistics